9 Results for "

Nsp14 MTase

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "Nsp14 MTase" in MCE Product Catalog:

Cat. No.: HY-124654
CAS No.: 1985669-27-9
Target:  

SARS-CoV

Research Areas:  

Metabolic Disease

SS148 is a dual inhibitor of nsp14/nsp16 MTase. SS148 significant inhibits nsp10–nsp16 with an IC50 of 1.2 μM .
loading...
    loading...
Cat. No.: HY-153719
CAS No.: 40420-48-2
Target:  

SARS-CoV

Research Areas:  

Infection

NSC111552 is a potent SARS-CoV-2 NSP14 MTase inhibitor. NSC111552 inhibits the FL-NAH binding to the SARS-CoV-2 NSP14 MTase with an IC50 of 5.1 μM .
loading...
    loading...
Cat. No.: HY-179048
CAS No.: 2766190-68-3
Research Areas:  

Infection

MH44 is an efficient inhibitor targeting the SARS-CoV-2 nsp14 N7-methyltransferase (N7-MTase) with an IC50 of 19 nM. MH44 exhibits moderate antiviral effects in SARS-CoV-2-infected A549-hACE2 cells and shows certain cytotoxicity at higher concentrations. MH44 can be used in the research on anti-SARS-CoV-2 .
loading...
    loading...
Cat. No.: HY-150680
CAS No.: 2816165-02-1
SARS-CoV-2 nsp14-IN-1 (Compound 3) is a prototypic bisubstrate inhibitor of SARS-CoV-2 Nsp14 MTase with an IC50 value of 0.061 μM. SARS-CoV-2 nsp14-IN-1 (Compound 3) has an excellent selectivity profile over a panel of human methyltransferases, can against apanel of 10 human MTases including histone lysine, proteinarginine, and DNA and RNA MTases .
loading...
    loading...
Cat. No.: HY-178027
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2 nsp14-IN-6 (Compound 35) is a SARS-CoV-2 Nsp14 MTase inhibitor with an IC50 of 0.24  μM. SARS-CoV-2 nsp14-IN-6 has potent antiviral activity against SARS-CoV-2 replication. SARS-CoV-2 nsp14-IN-6 increases lipophilicity, further improving cell permeability. SARS-CoV-2 nsp14-IN-6 can be used for human coronaviruses research .
loading...
    loading...
Cat. No.: HY-178027A
Target:  

SARS-CoV

Research Areas:  

Infection

SARS-CoV-2 nsp14-IN-6 (Compound 35) ammonium is a SARS-CoV-2 Nsp14 MTase inhibitor with an IC50 of 0.24  μM. SARS-CoV-2 nsp14-IN-6 ammonium has potent antiviral activity against SARS-CoV-2 replication. SARS-CoV-2 nsp14-IN-6 ammonium increases lipophilicity, further improving cell permeability. SARS-CoV-2 nsp14-IN-6 ammonium can be used for human coronaviruses research .
loading...
    loading...
Cat. No.: HY-168441
Target:  

SARS-CoV

Research Areas:  

Infection

NCGC00537446 is a dual Nsp14 MTase/ExoN inhibitor. NCGC00537446 can be used for the research of SARS-CoV-2 replication and infection .
loading...
    loading...
Cat. No.: HY-149362
Target:  

SARS-CoV

Research Areas:  

Infection

MTase-IN-1 (compound 26) is a potent and selective inhibitor of coronavirus nsp14 N7-methyltransferases, with an IC50 of 0.72 nM. MTase-IN-1 impairs viral RNA translation and immune evasion .
loading...
    loading...
Cat. No.: HY-159890
Target:  

SARS-CoV

Research Areas:  

Infection

MTI013 is a selective SARS-CoV-2 nsp14 Mtase inhibitor (IC50: 2.98 μM) and an antiviral agent (IC50: 10.33 μM in HCoV-229E-infected Huh7 cells). MTI013 also shows a synergistic antiviral effect with the RdRp inhibitor SHEN26 (HY-155488) .
loading...
    loading...